Three Penn School of Medicine Professors Named
Fellows of the
American Association for the Advancement of Science
(Philadelphia, PA) - Three faculty members of the University
of Pennsylvania School of Medicine were named Fellows of the
American Association for the Advancement of Science (AAAS) last week.
Three other Penn faculty were also elected, bringing the total to six
Penn professors in this year’s list of 376 new members.
AAAS recognizes members for their scientifically or socially distinguished
efforts to advance science or its applications. The new Fellows will be
officially inducted February 18 during the 2006 AAAS Annual Meeting in
This year’s AAAS Fellows were announced in the AAAS News & Notes
section of the journal Science on Oct. 28.
The new Penn AAAS Fellows are:
||Ian A. Blair, professor of pharmacology,
School of Medicine
Citation: For distinguished contributions to the field of mass
spectrometry and its applications to pharmaceutical medicine and for
moving autocoid biology forward with sensitive bioanalytical techniques.
||Richard L. Doty, professor of otorhinolaryngology,
School of Medicine, and director of Penn's Smell
and Taste Center
Citation: For distinguished contributions
to the field of sensory measurement and for the development of the
first widely used standardized test of olfactory function.
||Irwin B. Levitan, professor and chair of neuroscience
in Penn's School of Medicine
For pioneering studies of the regulation of neuronal electrical activity
with focus on the modulation of ion channels in the neuronal plasma
||Dawn A. Bonnell, professor of material sciences
and engineering, School of Engineering and Applied Sciences,
and director of Penn's Nano/Bio Interface Center
For seminal studies in interface mediated behavior in nanostructures,
as well as for leadership in the U.S. nanoscience community.
||Howard Kunreuther, professor of decision sciences
and business and public policy, Wharton School, and
co-director of Penn's Risk Management and Decision Processes Center
Citation: For distinguished contributions to the understanding
of environmental and technological risks and for developing tools
for risk assessment and management.
||Michael J. Therien, professor of chemistry, School
of Arts and Sciences
Citation: For seminal
contributions to the design, synthesis and physical characterization
of novel chemical structures with key application in electron transfer,
photonics, and medical imaging.
PENN Medicine is a $2.7 billion enterprise dedicated
to the related missions of medical education, biomedical research, and
high-quality patient care. PENN Medicine consists of the University of
Pennsylvania School of Medicine (founded in 1765 as the nation's first
medical school) and the University of Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #4 in the nation in U.S. News &
World Report’s most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the School
of Medicine is recognized worldwide for its superior education and training
of the next generation of physician-scientists and leaders of academic
The University of Pennsylvania Health System comprises: its flagship hospital,
the Hospital of the University of Pennsylvania, consistently rated one
of the nation’s “Honor Roll” hospitals by U.S. News
& World Report; Pennsylvania Hospital, the nation's first hospital;
Penn Presbyterian Medical Center; a faculty practice plan; a primary-care
provider network; two multispecialty satellite facilities; and home health
care and hospice.